Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its…
| Price | $246.56 |
|---|---|
| Market cap | $27.21B |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
| Exchange | NYSE |
| 52-week range | 171.18-248.7 |
| Dividend (TTM) | $3.32 per share |
| Beta | 0.55 |
Explore DGX's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.